tiprankstipranks
Advertisement
Advertisement
Nurix Therapeutics price target raised to $34 from $32 at Truist
PremiumThe FlyNurix Therapeutics price target raised to $34 from $32 at Truist
1M ago
Nurix Therapeutics price target raised to $33 from $30 at RBC Capital
Premium
The Fly
Nurix Therapeutics price target raised to $33 from $30 at RBC Capital
1M ago
Nurix Therapeutics price target raised to $40 from $34 at Stifel
Premium
The Fly
Nurix Therapeutics price target raised to $40 from $34 at Stifel
1M ago
Nurix Therapeutics price target raised to $33 from $26 at Baird
PremiumThe FlyNurix Therapeutics price target raised to $33 from $26 at Baird
2M ago
Nurix Maintained at Buy as Bexobrutideg Data Underscore Safety Edge; $34 Price Target Reaffirmed
Premium
Ratings
Nurix Maintained at Buy as Bexobrutideg Data Underscore Safety Edge; $34 Price Target Reaffirmed
2M ago
Nurix Highlights Promising Phase 1b Data for Bexobrutideg
Premium
Company Announcements
Nurix Highlights Promising Phase 1b Data for Bexobrutideg
2M ago
Nurix Therapeutics price target raised to $45 from $41 at Jefferies
PremiumThe FlyNurix Therapeutics price target raised to $45 from $41 at Jefferies
3M ago
Nurix Therapeutics price target raised to $34 from $26 at Needham
Premium
The Fly
Nurix Therapeutics price target raised to $34 from $26 at Needham
3M ago
Nurix Therapeutics downgraded to Equal Weight at Wells Fargo after Roche deal
Premium
The Fly
Nurix Therapeutics downgraded to Equal Weight at Wells Fargo after Roche deal
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100